Treatment of the experimental rats with anti-NLRP3 antibodies blocked the myocarditis-induced activation of Ca2+ signaling, implicating NLRP3 in the dysregulation of Ca2+ signaling in myocarditis. This evidence concerns the gene NLRP3 and myocarditis.